BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zanghì A, D'Amico E, Patti F. Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment. Expert Rev Neurother 2020;20:771-82. [PMID: 31971026 DOI: 10.1080/14737175.2020.1721282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Concerto C, Rodolico A, Ciancio A, Messina C, Natale A, Mineo L, Battaglia F, Aguglia E. Vitamin D and Depressive Symptoms in Adults with Multiple Sclerosis: A Scoping Review. IJERPH 2021;19:199. [DOI: 10.3390/ijerph19010199] [Reference Citation Analysis]
2 Barboza A, Burgos M, Cáceres F, Carrá A, Correale J, Cristiano E, Patrucco L, Piedrabuena R, Rojas JI, Sinay V, Ysrraelit MC. Esclerosis múltiple altamente activa y su influencia en la elección del tratamiento. Neurología Argentina 2021;13:241-245. [DOI: 10.1016/j.neuarg.2021.10.002] [Reference Citation Analysis]
3 Zanghì A, D'Amico E, Lo Fermo S, Patti F. Exploring polypharmacy phenomenon in newly diagnosed relapsing-remitting multiple sclerosis: a cohort ambispective single-centre study. Ther Adv Chronic Dis 2021;12:2040622320983121. [PMID: 33717425 DOI: 10.1177/2040622320983121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
4 Naser Moghadasi A. The role of the brain in the treatment of multiple sclerosis as a connectomopathy. Med Hypotheses 2020;143:110090. [PMID: 32679428 DOI: 10.1016/j.mehy.2020.110090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]